Dyadic International, Inc. (DYAI)
0.52
+0.02 (4.00%)
Upcoming Events
Latest Headlines
Q3 Virtual Investor Summit Presentations Now Available On Demand
August 31, 2026 6:16 PM - StreetInsider
Form SCHEDULE 13G/A DYADIC INTERNATIONAL Filed by: Francisco Trust under agreement dated February 28, 1996
August 17, 2026 9:25 AM - SEC Filing
Form 8-K DYADIC INTERNATIONAL For: Aug 13
August 14, 2026 9:18 AM - SEC Filing
Form 424B5 DYADIC INTERNATIONAL
August 13, 2026 5:25 PM - SEC Filing
Dyadic International (DYAI) PT Lowered to $4 at Craig-Hallum
August 13, 2026 9:19 AM - StreetInsider
Dyadic International raises $2.9M via stock offering and warrants
August 13, 2026 8:00 AM - StreetInsider
Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private PlacementÂ
August 13, 2026 8:00 AM - StreetInsider
Form 10-Q DYADIC INTERNATIONAL For: Jun 30
August 12, 2026 8:46 AM - SEC Filing
Form 8-K DYADIC INTERNATIONAL For: Aug 12
August 12, 2026 8:46 AM - SEC Filing
Dyadic International, Inc. (DYAI) Misses Q2 EPS by 2c
August 12, 2026 8:33 AM - StreetInsider
Dyadic posts wider Q2 loss as costs rise despite flat revenue
August 12, 2026 8:32 AM - StreetInsider
Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas
August 12, 2026 8:30 AM - Globe NewsWire
Dyadic signs new dairy protein deal with European biotech firm
August 4, 2026 7:28 AM - StreetInsider
Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement
August 4, 2026 7:25 AM - StreetInsider
Dyadic to Report Q2 2026 Financial Results and Host Conference Call on Wednesday August 12, 2026
August 3, 2026 4:30 PM - StreetInsider
Form 144 DYADIC INTERNATIONAL Filed by: Francisco Trust under agreement dated February 28, 1996
July 29, 2026 3:46 PM - SEC Filing
Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days
July 28, 2026 8:30 AM - StreetInsider
Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days
July 28, 2026 8:30 AM - StreetInsider
Form 4 DYADIC INTERNATIONAL For: Jul 22 Filed by: Francisco Trust under agreement dated February 28, 1996
July 24, 2026 5:11 PM - SEC Filing
Form 8-K DYADIC INTERNATIONAL For: Jul 24
July 24, 2026 8:00 AM - SEC Filing
Dyadic regains Nasdaq compliance, stock to remain listed
July 24, 2026 7:30 AM - StreetInsider
Dyadic Announces Continued Listing on the Nasdaq Capital Market
July 24, 2026 7:30 AM - StreetInsider
Form 144 DYADIC INTERNATIONAL Filed by: Francisco Trust under agreement dated February 28, 1996
July 21, 2026 5:52 PM - SEC Filing
Dyadic launches enzyme program targeting cellulose processing
July 16, 2026 8:03 AM - StreetInsider
Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme Program
July 16, 2026 8:00 AM - StreetInsider
Dyadic receives full $3.1M Gates grant, advances C1 platform work
July 7, 2026 7:25 AM - StreetInsider
Global Collaborations Continue to Validate Dyadic’s C1 Platform and Expands Commercial Potential
July 7, 2026 7:25 AM - StreetInsider
Form SCHEDULE 13G/A DYADIC INTERNATIONAL Filed by: Francisco Trust under agreement dated February 28, 1996
July 6, 2026 6:30 AM - SEC Filing
Form 4 DYADIC INTERNATIONAL For: Mar 08 Filed by: Francisco Trust under agreement dated February 28, 1996
July 6, 2026 6:30 AM - SEC Filing
Dyadic wins Japan patent for protein expression technology
June 29, 2026 7:28 AM - StreetInsider
Dyadic Expands IP Protection and Business Development Activities in Japan
June 29, 2026 7:25 AM - StreetInsider
An Interview with the President & COO: How Dyadic is Commercializing Its Protein Platform Across Multi-Billion-Dollar Markets
June 22, 2026 8:49 AM - StreetInsider
Form 8-K DYADIC INTERNATIONAL For: Jun 18
June 22, 2026 8:30 AM - SEC Filing
Form DEFA14A DYADIC INTERNATIONAL
June 18, 2026 9:56 AM - SEC Filing
Form 8-K DYADIC INTERNATIONAL For: Jun 18
June 18, 2026 9:56 AM - SEC Filing
Form 8-K DYADIC INTERNATIONAL For: Jun 15
June 15, 2026 4:31 PM - SEC Filing
Dyadic sees increased interest in C1 platform amid Ebola outbreak response
June 15, 2026 7:27 AM - StreetInsider
Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption
June 15, 2026 7:25 AM - StreetInsider
Full Article List